News on NMS
 Practice Patients feel they are benefiting from the new medicines service (NMS) and are using the service to have a “wider conversation” with pharmacists about their health, initial findings from an independent evaluation of the service has found. |
 Practice PSNC will have to convince the government to stump up another six months of funding for the new medicines service without evidence of its success because of yet another delay in the evaluation of the service. |
 Practice European pharmacists should look to the UK as a “shining example” of how to maintain their professional status by offering innovative services, PGEU general secretary John Chave has said. |
 Commissioning Although the Department of Health is not due to decide on the future of the NMS until the end of the year, PSNC chief executive Sue Sharpe is confident that the PSNC's own evaluation is strong enough to ensure the service is extended |
New medicine service - everything you need
Week by week C+D will create a 14-part ‘Tools for NMS and MUR' series giving you essential support as you prepare for the new medicine service (NMS) and target MUR groups.
 A best-practice guide on the use of the potentially toxic drug methotrexate in primary care |
 Practical Approach David Spencer, pharmacist at the Update Pharmacy, is having his monthly meeting with GP Mo Merali, to whose practice he provides prescribing advice. What are the problems with the cases Mo has referred to David? |
 Hypertension is a major risk factor for both cerebro- and cardiovascular disease (CVD) with no outward signs or symptoms. |
 A clinical photoguide for pharmacists on diabetic retinopathy - the most common cause of blindness in working adults |
 Type 2 diabetes is caused by impaired insulin secretion and insulin resistance. It is associated with excess body weight and physical inactivity. |
 Acute upper gastrointestinal bleeding (AUGIB) is terrifying – but passing blood by mouth or rectum is not necessarily sinister, and patients’ chances of recovery from peptic ulcer and varices have improved over the years as a result of advances in treatment. |
 In the final part of our guide to targeted MURs, Trudy Thomas reveals how to get the most from asthma and COPD consultations |
 The two major respiratory conditions, asthma and chronic obstructive pulmonary disease (COPD), are associated with significant morbidity and mortality in the UK. According to recent data by Asthma UK, 4.3 million adults and 1.1 million children are being treated for asthma. |
 Part 7 in C+D's Tools for NMS and MURs series provides a wall chart to help pharmacy staff identify which patients groups are eligible for these two services and when they should alert the pharmacist |
 With targeted MURs launching in England in two weeks, Trudy Thomas looks at counselling patients with high risk medicines |
 One of the most common drug-related causes of hospital admissions is bleeding caused by inappropriate anticoagulation. Many patients may be confused by the advice that has been given and, as initially there may be no symptoms as a result of non-compliance, patients often find it harder to adhere to treatment, causing haemorrhage, stroke or thrombosis. |
 The new medicine service (NMS) will provide support to people newly prescribed a medicine by helping them to improve their medication adherence. This should lead to a reduction in medicines wastage, reduce medicines-related hospital admissions and improve quality of life for patients. |
 With targeted MURs launching in England in three weeks, Trudy Thomas looks at counselling patients discharged from hospital |
 Confused about targeted MURs? In the first part of our four-part guide, Trudy Thomas reveals the service’s details and the steps you need to take to be ready for the changes on October 1 |
More on the new medicine service
 How can you help recruit patients for services such as the NMS? Find out with our useful tips and tactics for dispensary staff |
 With a decision on the future of NMS to be made this summer, pharmacy leaders explain how much value the service has added to the profession |
 From embracing NMS to collaborating on local service commissioning, James Waldron puts readers' questions to C+D Senator and Lloydspharmacy chief Andy Murdock |
 Time is once again running out, writes Jennifer Richardson, on this occasion to claim not just this year's cash but the future of the NMS |
|
Senate Against a backdrop of a double whammy of funding cuts, C+D Senators were divided on the best route to financial salvation for the sector |
New Medicine Service Toolkit
Buy Online (£6+VAT)
How will I benefit?
This four module NMS Toolkit will provide you with all the information you need to complete the ‘self-assessment of readiness' that must be submitted before you can offer the New Medicine Service.
Properly completing the course means you can download a completed self-assessment certificate which you only need to sign and date…
In addition, each module comes with its own CPD log sheet, enabling you to use it as a CPD entry in your ‘Plan and Record' portfolio at uptodate.org.uk.
What will I learn?
The four modules in the NMS Toolkit cover:
· Module 1: An introduction to the NMS, outlining the purpose of the service and its aims and outcomes
· Module 2: The service specification and how to deliver the NMS effectively
· Module 3: A five point guide to getting the most out of NMS consultations – face-to-face and over the phone
· Module 4: Essential counselling points for the four targeted therapy areas for the NMS
To complete the assessment for each module online go to My CPD. Find NMS Toolkit in your course list and click on 'View Exams'. Use the menu options on the Exam page to download your CPD logsheet, and print or e-mail a certificate when you have completed the assessment.
Use the menu option on the Course page to download your ‘Self-assessment of Readiness' certificate
Enquiries
Email: pharmacytraining@chemistanddruggist.co.uk
Phone: 020 7921 8425
|
This module sets out what the criteria are for you to provide the sevice, and give you an understanding of the purpose and background of the service, and the aims and intended outcomes of the service |
|
This module sets out the service specification and all aspects of how to deliver the service effectively. |
|
A five point guide to the setting the scene and using appropriate counselling skills to ensure you get the best results from NMS consultations, whether face-to-face or over the phone. |
|
Essential counselling points for patients on newly prescribed medicines in the four NMS target areas of asthma and COPD, type 2 diabetes, anti coagulant therapy, and hypertension. |
